Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial.
The effectiveness and costs associated with addition of pharmacist-led group medical visits to standard care for patients with Type-2 Diabetes Mellitus (T2DM) is unknown.Randomized-controlled-trial in three US Veteran Health Administration (VHA) Hospitals, where 250 patients with T2DM, HbA1c >7%...
Main Authors: | Wen-Chih Wu, Tracey H Taveira, Sean Jeffery, Lan Jiang, Lisa Tokuda, Joanna Musial, Lisa B Cohen, Fred Uhrle |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5908172?pdf=render |
Similar Items
-
The impact of community–pharmacist-led medication reconciliation process: Pharmacist–patient-centered medication reconciliation
by: Mohammad M AlAhmad, et al.
Published: (2020-01-01) -
Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care
by: Sarah Dineen-Griffin, et al.
Published: (2020-07-01) -
Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost
by: Maeng DD, et al.
Published: (2018-09-01) -
Using the patient activation measure during a pharmacist-led rural patient home visit pilot project
by: Frazier, K., et al.
Published: (2021) -
Pharmacist-Led Medication Review: Supports for New Role of Pharmacists
by: Kourosh Sadeghi, et al.
Published: (2015-10-01)